1-methyltryptophan has been researched along with Precancerous Conditions in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, T; Hoshi, M; Ito, H; Moriwaki, H; Nagano, J; Ninomiya, S; Ogawa, K; Saito, K; Sakai, H; Seishima, M; Shimizu, M; Tanaka, T; Tsurumi, H | 1 |
1 other study(ies) available for 1-methyltryptophan and Precancerous Conditions
| Article | Year |
|---|---|
Suppression of azoxymethane-induced colonic preneoplastic lesions in rats by 1-methyltryptophan, an inhibitor of indoleamine 2,3-dioxygenase.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Carcinogens; Colonic Neoplasms; Indoleamine-Pyrrole 2,3,-Dioxygenase; Male; Precancerous Conditions; Rats; Rats, Inbred F344; Tryptophan | 2012 |